UT Houston Wins $30M for Genome-based Disease Studies | GenomeWeb

NEW YORK (GenomeWeb News) – The University of Texas Health Science Center at Houston will use nearly $30 million of the $49 million in funding it has received from the American Recovery and Reinvestment Act for genomics research related to cardiovascular and other diseases, according to UTHSC.

Included in the stimulus funding is $26 million for a study at the Human Genetics Centers at both The University of Texas School of Public Health and the Brown Foundation Institute of Molecular Medicine that will look for genetic factors associated with heart, lung, and blood diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.